Balance Sheet Moderna, Inc.

Equities

MRNA

US60770K1079

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 01:30:00 15/04/2026 am IST			5-day change	1st Jan Change
52.84 ^USD	+4.26%		+8.35%	+79.18%

14/04	Leerink Partners Adjusts Moderna PT to $21 From $12, Maintains Underperform Rating	MT
14/04	Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery -- Update	DJ

7a81e7293fdd776ab632.U5SMWSNwA73yHgTTBjw6fmciFMibpYjGO6dDDTUa5dA.H_L5KWURT4W7eVKnYwoJDwlDZbGik9-WVdQFT2ZP1bsn0elrWSp09cUpQQ

Published financial data: MODERNA, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.85TCr	1.93TCr	667.1Cr	310.9Cr	181.8Cr
Other Revenues, Total	-	-	18Cr	13Cr	13Cr
Total Revenues	1.85TCr	1.93TCr	684.8Cr	323.6Cr	194.4Cr
Cost of Goods Sold, Total	460.8Cr	871.1Cr	953.8Cr	600.7Cr	400Cr
Gross Profit	1.39TCr	1.06TCr	-269Cr	-277.1Cr	-205.6Cr
Selling General & Admin Expenses, Total	57Cr	113.2Cr	154.9Cr	117.4Cr	101.8Cr
Other Operating Expenses, Total	57Cr	113.2Cr	154.9Cr	117.4Cr	101.8Cr
Operating Income	1.33TCr	942Cr	-423.9Cr	-394.5Cr	-307.4Cr
Interest Expense, Total	-1.8Cr	-2.9Cr	-3.8Cr	-2.4Cr	-1Cr
Interest And Investment Income	1.8Cr	20Cr	42Cr	42Cr	31Cr
Net Interest Expenses	0	17Cr	38Cr	40Cr	30Cr
Currency Exchange Gains (Loss)	-80L	4.8Cr	-	-	-
Other Non Operating Income (Expenses)	-40L	-4.4Cr	-1.4Cr	-70L	70L
EBT, Excl. Unusual Items	1.33TCr	959.5Cr	-387Cr	-355.1Cr	-276.3Cr
Gain (Loss) On Sale Of Investments	10L	-2Cr	-7.2Cr	-5.6Cr	-50L
Gain (Loss) On Sale Of Assets	-	-	-	-	-
EBT, Incl. Unusual Items	1.33TCr	957.5Cr	-394.2Cr	-360.7Cr	-276.8Cr
Income Tax Expense	108.3Cr	121.3Cr	77Cr	-4.6Cr	5.4Cr
Earnings From Continuing Operations	1.22TCr	836.2Cr	-471.4Cr	-356.1Cr	-282.2Cr
Net Income to Company	1.22TCr	836.2Cr	-471.4Cr	-356.1Cr	-282.2Cr
Net Income - (IS)	1.22TCr	836.2Cr	-471.4Cr	-356.1Cr	-282.2Cr
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	1.22TCr	836.2Cr	-471.4Cr	-356.1Cr	-282.2Cr
Net Income to Common Excl. Extra Items	1.22TCr	836.2Cr	-471.4Cr	-356.1Cr	-282.2Cr
Per Share Items
Net EPS - Basic	30.28	21.22	-12.34	-9.27	-7.25
Basic EPS - Continuing Operations	30.28	21.22	-12.34	-9.27	-7.25
Basic Weighted Average Shares Outstanding	40Cr	39Cr	38Cr	38Cr	39Cr
Net EPS - Diluted	28.29	20.12	-12.34	-9.28	-7.25
Diluted EPS - Continuing Operations	28.29	20.12	-12.34	-9.28	-7.25
Diluted Weighted Average Shares Outstanding	43Cr	42Cr	38Cr	38Cr	39Cr
Normalized Basic EPS	20.6	15.22	-6.33	-5.78	-4.44
Normalized Diluted EPS	19.26	14.42	-6.33	-5.78	-4.44
Payout Ratio	-	-	-	-	-
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	1.35TCr	976.8Cr	-361.8Cr	-375.6Cr	-285.9Cr
EBITA	1.33TCr	942Cr	-423.9Cr	-394.5Cr	-307.4Cr
EBIT	1.33TCr	942Cr	-423.9Cr	-394.5Cr	-307.4Cr
EBITDAR	1.37TCr	998.1Cr	-341.5Cr	-359.8Cr	-274.8Cr
Total Revenues (As Reported)	1.85TCr	1.93TCr	684.8Cr	323.6Cr	194.4Cr
Effective Tax Rate - (Ratio)	8.15	12.67	-19.58	1.28	-1.95
Current Domestic Taxes	133.9Cr	173.4Cr	-15Cr	-5.8Cr	1.5Cr
Current Foreign Taxes	4Cr	5.7Cr	2.4Cr	1.3Cr	2.9Cr
Total Current Taxes	137.9Cr	179.1Cr	-13Cr	-4.5Cr	4.4Cr
Deferred Domestic Taxes	-29Cr	-58Cr	90Cr	-	-
Deferred Foreign Taxes	-20L	-20L	50L	-10L	1Cr
Total Deferred Taxes	-30Cr	-58Cr	90Cr	-10L	1Cr
Normalized Net Income	830.25Cr	599.69Cr	-241.88Cr	-221.94Cr	-172.69Cr
Interest on Long-Term Debt	1.7Cr	2.9Cr	3.8Cr	2.4Cr	30L
Supplemental Operating Expense Items
Advertising Expense	-	-	20Cr	15Cr	-
Selling and Marketing Expenses	-	-	20Cr	15Cr	-
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	199.1Cr	329.5Cr	484.5Cr	454.3Cr	313.2Cr
Net Rental Expense, Total	17Cr	21Cr	20Cr	16Cr	11Cr
Imputed Operating Lease Interest Expense	4.32Cr	4.67Cr	5.05Cr	3.05Cr	86.54L
Imputed Operating Lease Depreciation	13Cr	17Cr	15Cr	13Cr	10Cr
Stock-Based Comp., COGS (Total)	9Cr	14Cr	19Cr	29Cr	32Cr
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	5.2Cr	8.8Cr	11Cr	14Cr	17Cr
Total Stock-Based Compensation	14Cr	23Cr	30Cr	43Cr	48Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	684.8Cr	320.5Cr	290.7Cr	192.7Cr	259.5Cr
Short Term Investments	387.9Cr	669.7Cr	569.7Cr	509.8Cr	320.4Cr
Total Cash And Short Term Investments	1.07TCr	990.2Cr	860.4Cr	702.5Cr	579.9Cr
Accounts Receivable, Total	317.5Cr	138.5Cr	89Cr	36Cr	18Cr
Other Receivables	12Cr	24Cr	19Cr	23Cr	10Cr
Notes Receivable	-	3.6Cr	-	-	-
Total Receivables	329.6Cr	166.4Cr	108.1Cr	59Cr	28Cr
Inventory	144.1Cr	116.8Cr	27Cr	12Cr	15Cr
Prepaid Expenses	13Cr	22Cr	27Cr	17Cr	17Cr
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	48Cr	48Cr	10Cr	19Cr	14Cr
Total Current Assets	1.61TCr	1.34TCr	1.03TCr	809.9Cr	654.4Cr
Gross Property Plant And Equipment	173.5Cr	279.7Cr	309.1Cr	348.2Cr	359Cr
Accumulated Depreciation	-35Cr	-66Cr	-43Cr	-53Cr	-74Cr
Net Property Plant And Equipment	138.3Cr	213.9Cr	265.8Cr	295.5Cr	285.3Cr
Long-term Investments	684.3Cr	836Cr	474.3Cr	250.8Cr	234.2Cr
Goodwill	-	-	5.2Cr	5.2Cr	5.2Cr
Other Intangibles, Total	-	-	4.4Cr	4Cr	4.5Cr
Deferred Tax Assets Long-Term	33Cr	98Cr	8.1Cr	-	8.1Cr
Other Long-Term Assets, Total	4.6Cr	95Cr	52Cr	49Cr	42Cr
Total Assets	2.47TCr	2.59TCr	1.84TCr	1.41TCr	1.23TCr
Liabilities
Accounts Payable, Total	30Cr	49Cr	52Cr	40Cr	32Cr
Accrued Expenses, Total	147.2Cr	183.3Cr	106.9Cr	90Cr	83Cr
Current Portion of Leases	21Cr	20Cr	2.5Cr	3.7Cr	4.2Cr
Current Income Taxes Payable	88Cr	4.8Cr	6.3Cr	-	-
Unearned Revenue Current, Total	625.3Cr	203.8Cr	57Cr	15Cr	9.9Cr
Other Current Liabilities	1.4Cr	32Cr	77Cr	71Cr	70Cr
Total Current Liabilities	912.8Cr	492.3Cr	301.5Cr	220.6Cr	198.7Cr
Long-Term Debt	-	-	-	-	59Cr
Long-Term Leases	70Cr	100.4Cr	121.8Cr	71Cr	67Cr
Unearned Revenue Non Current	62Cr	67Cr	8.3Cr	5.8Cr	15Cr
Other Non Current Liabilities	7.6Cr	14Cr	26Cr	27Cr	28Cr
Total Liabilities	1.05TCr	673.5Cr	457.2Cr	324.1Cr	368.8Cr
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	-	-	-	-	-
Additional Paid In Capital	421.1Cr	117.3Cr	37Cr	87Cr	138.2Cr
Retained Earnings	995.8Cr	1.83TCr	1.36TCr	1TCr	722.3Cr
Comprehensive Income and Other	-2.4Cr	-37Cr	-12Cr	-1Cr	4.5Cr
Total Common Equity	1.41TCr	1.91TCr	1.39TCr	1.09TCr	865Cr
Total Equity	1.41TCr	1.91TCr	1.39TCr	1.09TCr	865Cr
Total Liabilities And Equity	2.47TCr	2.59TCr	1.84TCr	1.41TCr	1.23TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	40Cr	39Cr	38Cr	39Cr	39Cr
ECS Total Common Shares Outstanding	40Cr	38Cr	38Cr	39Cr	39Cr
Book Value / Share	35.1	49.67	36.27	28.24	21.95
Tangible Book Value	1.41TCr	1.91TCr	1.38TCr	1.08TCr	855.3Cr
Tangible Book Value Per Share	35.1	49.67	36.02	28	21.71
Total Debt	92Cr	120Cr	124.3Cr	75Cr	130.5Cr
Net Debt	-1.67TCr	-1.7TCr	-1.2TCr	-877.2Cr	-683Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	90L	80L	-	-	-
Debt Equivalent Oper. Leases	138.4Cr	170.4Cr	162.4Cr	126.4Cr	89Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	87Cr	58Cr	16Cr	6.3Cr	9.1Cr
Inventories - Work In Process, Total	34Cr	20Cr	1.5Cr	2.6Cr	2.9Cr
Inventories - Finished Goods, Total	23Cr	17Cr	2.4Cr	2.8Cr	3.3Cr
Land - (BS)	-	1.1Cr	2.2Cr	5.9Cr	7.8Cr
Buildings, Total	-	-	-	74Cr	118.3Cr
Machinery, Total	20Cr	34Cr	44Cr	52Cr	78Cr
Full Time Employees	2.7T	3.9T	5.6T	5.8T	4.7T
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	34Cr	30L

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.22TCr	836.2Cr	-471.4Cr	-356.1Cr	-282.2Cr
Depreciation & Amortization - CF	23Cr	35Cr	62Cr	19Cr	22Cr
Depreciation & Amortization, Total	23Cr	35Cr	62Cr	19Cr	22Cr
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	5.4Cr	3.1Cr	-2.6Cr	-4.3Cr	-5.9Cr
Stock-Based Compensation (CF)	14Cr	23Cr	30Cr	43Cr	48Cr
Other Operating Activities, Total	-32Cr	-53Cr	84Cr	6Cr	7.7Cr
Change In Accounts Receivable	-178.4Cr	179Cr	49Cr	53Cr	16Cr
Change In Inventories	-139.4Cr	49Cr	75Cr	8.3Cr	-3.4Cr
Change In Accounts Payable	20Cr	24Cr	1.3Cr	-6.9Cr	-9.2Cr
Change in Unearned Revenues	282.4Cr	-415.7Cr	-206Cr	-44Cr	4.1Cr
Change In Income Taxes	88Cr	-83Cr	1.5Cr	-	-
Change In Deferred Taxes	-	-	-	-	-
Change in Other Net Operating Assets	58Cr	-99Cr	65Cr	-19Cr	16Cr
Cash from Operations	1.36TCr	498.1Cr	-311.8Cr	-300.4Cr	-187.3Cr
Capital Expenditure	-28Cr	-40Cr	-71Cr	-105.1Cr	-19Cr
Cash Acquisitions	-	-	-8.5Cr	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-1Cr
Investment in Marketable and Equity Securities, Total	-823.9Cr	-473.6Cr	502.1Cr	300Cr	214.8Cr
Other Investing Activities, Total	-	-4Cr	-2.3Cr	-	-
Cash from Investing	-852.3Cr	-517.6Cr	420.6Cr	194.9Cr	194.6Cr
Long-Term Debt Issued, Total	-	-	-	-	60Cr
Total Debt Issued	-	-	-	-	60Cr
Long-Term Debt Repaid, Total	-14Cr	-18Cr	-27Cr	-1Cr	-1.8Cr
Total Debt Repaid	-14Cr	-18Cr	-27Cr	-1Cr	-1.8Cr
Issuance of Common Stock	12Cr	6.5Cr	4.6Cr	6.6Cr	3.5Cr
Repurchase of Common Stock	-86Cr	-332.9Cr	-115.3Cr	-	-20L
Issuance of Preferred Stock	-	-	-	-	-
Repurchase of Preferred Stock	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-2.2Cr
Cash from Financing	-87Cr	-344.8Cr	-137.7Cr	5.6Cr	59Cr
Foreign Exchange Rate Adjustments	-	-	-	-	20L
Net Change in Cash	422.4Cr	-364.3Cr	-29Cr	-100Cr	67Cr
Supplemental Items
Cash Interest Paid	1.4Cr	2.5Cr	3.9Cr	2.4Cr	1Cr
Cash Income Tax Paid (Refund)	48Cr	272.9Cr	-36Cr	20Cr	2.6Cr
Levered Free Cash Flow	929.28Cr	366.84Cr	-238.31Cr	-308.76Cr	-132.65Cr
Unlevered Free Cash Flow	930.4Cr	368.65Cr	-235.94Cr	-307.26Cr	-132.02Cr
Change In Net Working Capital	-90Cr	237.5Cr	-7.1Cr	17Cr	-10Cr
Net Debt Issued / Repaid	-14Cr	-18Cr	-27Cr	-1Cr	58Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	51.93	23.3	-11.97	-15.14	-14.51
Return on Total Capital	93.06	33.28	-14.96	-18.44	-17.79
Return On Equity %	146.08	50.27	-28.59	-28.77	-28.87
Return on Common Equity	146.08	50.27	-28.59	-28.77	-28.87
Margin Analysis
Gross Profit Margin %	75.05	54.78	-39.28	-85.63	-105.76
SG&A Margin	3.07	5.88	22.62	36.28	52.37
EBITDA Margin %	73.24	50.71	-52.83	-116.07	-147.07
EBITA Margin %	71.98	48.9	-61.9	-121.91	-158.13
EBIT Margin %	71.98	48.9	-61.9	-121.91	-158.13
Income From Continuing Operations Margin %	66.06	43.41	-68.84	-110.04	-145.16
Net Income Margin %	66.06	43.41	-68.84	-110.04	-145.16
Net Avail. For Common Margin %	66.06	43.41	-68.84	-110.04	-145.16
Normalized Net Income Margin	44.95	31.13	-35.32	-68.58	-88.83
Levered Free Cash Flow Margin	50.31	19.04	-34.8	-95.41	-68.24
Unlevered Free Cash Flow Margin	50.37	19.14	-34.45	-94.95	-67.91
Asset Turnover
Asset Turnover	1.15	0.76	0.31	0.2	0.15
Fixed Assets Turnover	20.87	10.94	2.86	1.15	0.67
Receivables Turnover (Average Receivables)	8.09	8.45	5.86	4.97	6.71
Inventory Turnover (Average Inventory)	6.19	6.02	13.27	37.66	29.63
Short Term Liquidity
Current Ratio	1.76	2.73	3.42	3.67	3.29
Quick Ratio	1.54	2.34	3.21	3.45	3.06
Operating Cash Flow to Current Liabilities	1.49	1.01	-1.03	-1.36	-0.94
Days Sales Outstanding (Average Receivables)	45.11	43.2	62.29	73.58	54.41
Days Outstanding Inventory (Average Inventory)	58.93	60.67	27.51	9.72	12.32
Average Days Payable Outstanding	9.73	17.67	21.27	28.58	32.65
Cash Conversion Cycle (Average Days)	94.32	86.21	68.54	54.71	34.08
Long Term Solvency
Total Debt/Equity	6.48	6.28	8.97	6.85	15.09
Total Debt / Total Capital	6.08	5.9	8.23	6.41	13.11
LT Debt/Equity	4.98	5.25	8.79	6.51	14.6
Long-Term Debt / Total Capital	4.68	4.94	8.07	6.1	12.69
Total Liabilities / Total Assets	42.66	26.05	24.81	22.92	29.89
EBIT / Interest Expense	738.67	324.83	-111.55	-164.38	-307.4
EBITDA / Interest Expense	761.17	344.17	-89.87	-149.92	-274.8
(EBITDA - Capex) / Interest Expense	745.39	330.38	-108.47	-193.71	-294
Total Debt / EBITDA	0.07	0.12	-0.36	-0.21	-0.47
Net Debt / EBITDA	-1.22	-1.71	3.53	2.44	2.49
Total Debt / (EBITDA - Capex)	0.07	0.13	-0.3	-0.16	-0.44
Net Debt / (EBITDA - Capex)	-1.24	-1.78	2.92	1.89	2.32
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.2T	4.29	-64.45	-52.75	-39.93
Gross Profit, 1 Yr. Growth %	-2.51T	-23.88	-125.49	3.01	-25.8
EBITDA, 1 Yr. Growth %	-1.95T	-27.79	-137.04	3.81	-23.88
EBITA, 1 Yr. Growth %	-1.84T	-29.15	-145	-6.94	-22.08
EBIT, 1 Yr. Growth %	-1.84T	-29.15	-145	-6.94	-22.08
Earnings From Cont. Operations, 1 Yr. Growth %	-1.73T	-31.47	-156.37	-24.46	-20.75
Net Income, 1 Yr. Growth %	-1.73T	-31.47	-156.37	-24.46	-20.75
Normalized Net Income, 1 Yr. Growth %	-1.88T	-27.77	-140.33	-8.24	-22.19
Diluted EPS Before Extra, 1 Yr. Growth %	-1.54T	-28.88	-161.33	-24.8	-21.77
Accounts Receivable, 1 Yr. Growth %	128.25	-56.38	-35.6	-59.87	-48.6
Inventory, 1 Yr. Growth %	2.97T	-32.41	-76.88	-42.08	30.77
Net Property, Plant and Equip., 1 Yr. Growth %	257.36	54.66	24.26	11.17	-3.45
Total Assets, 1 Yr. Growth %	236.23	4.82	-28.74	-23.25	-12.76
Tangible Book Value, 1 Yr. Growth %	452.32	35.19	-28.06	-21.43	-20.87
Common Equity, 1 Yr. Growth %	452.32	35.19	-27.55	-21.32	-20.65
Cash From Operations, 1 Yr. Growth %	571.93	-63.43	-162.6	-3.66	-37.65
Capital Expenditures, 1 Yr. Growth %	317.65	40.84	76.75	48.66	-81.73
Levered Free Cash Flow, 1 Yr. Growth %	324.3	-60.53	-164.95	29.56	-57.04
Unlevered Free Cash Flow, 1 Yr. Growth %	323.6	-60.38	-163.98	30.23	-57.03
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.65T	389.78	-39.11	-59.01	-46.72
Gross Profit, 2 Yr. CAGR %	463.88	328.38	-55.95	-48.76	-12.58
EBITDA, 2 Yr. CAGR %	412.52	265.3	-48.28	-37.99	-11.11
EBITA, 2 Yr. CAGR %	393.47	251.37	-43.54	-35.29	-14.84
EBIT, 2 Yr. CAGR %	393.47	251.37	-43.54	-35.29	-14.84
Earnings From Cont. Operations, 2 Yr. CAGR %	387.23	234.58	-37.84	-34.74	-22.63
Net Income, 2 Yr. CAGR %	387.23	234.58	-37.84	-34.74	-22.63
Normalized Net Income, 2 Yr. CAGR %	407.88	259.12	-46.03	-39.1	-16.28
Diluted EPS Before Extra, 2 Yr. CAGR %	326.82	220.34	-33.95	-32.09	-23.33
Accounts Receivable, 2 Yr. CAGR %	2.33T	-0.22	-47	-49.16	-54.58
Inventory, 2 Yr. CAGR %	-	398.51	-60.47	-68.35	-12.97
Net Property, Plant and Equip., 2 Yr. CAGR %	119.17	135.1	38.63	17.54	3.6
Total Assets, 2 Yr. CAGR %	293.96	87.73	-13.57	-26.05	-18.17
Tangible Book Value, 2 Yr. CAGR %	246.99	173.26	-1.38	-24.82	-21.15
Common Equity, 2 Yr. CAGR %	246.99	173.26	-1.03	-24.5	-20.98
Cash From Operations, 2 Yr. CAGR %	444.73	56.76	-52.15	-22.34	-22.49
Capital Expenditures, 2 Yr. CAGR %	197.91	142.54	57.78	62.1	-47.89
Levered Free Cash Flow, 2 Yr. CAGR %	431.67	29.42	-49.36	-8.26	-25.02
Unlevered Free Cash Flow, 2 Yr. CAGR %	431.99	29.55	-49.64	-8.7	-25.2
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	415.2	584.74	104.31	-44.04	-53.44
Gross Profit, 3 Yr. CAGR %	251.57	189.26	67.25	-41.53	-42.03
EBITDA, 3 Yr. CAGR %	226.58	166.69	70.34	-34.76	-33.6
EBITA, 3 Yr. CAGR %	218.05	158.4	77.11	-33.3	-31.15
EBIT, 3 Yr. CAGR %	218.05	158.4	77.11	-33.3	-31.15
Earnings From Cont. Operations, 3 Yr. CAGR %	216.54	153.39	84.79	-33.67	-30.38
Net Income, 3 Yr. CAGR %	216.54	153.39	84.79	-33.67	-30.38
Normalized Net Income, 3 Yr. CAGR %	224	165.1	73.27	-35.58	-33.92
Diluted EPS Before Extra, 3 Yr. CAGR %	78.74	134.87	84.63	-31.03	-28.83
Accounts Receivable, 3 Yr. CAGR %	531.87	536.58	-13.77	-51.69	-48.97
Inventory, 3 Yr. CAGR %	-	-	79.1	-59.24	-49.21
Net Property, Plant and Equip., 3 Yr. CAGR %	86.86	95.13	90.09	28.8	10.08
Total Assets, 3 Yr. CAGR %	132.53	153.39	35.93	-16.93	-21.86
Tangible Book Value, 3 Yr. CAGR %	109.87	153.43	75.14	-8.58	-23.52
Common Equity, 3 Yr. CAGR %	109.87	153.43	75.54	-8.32	-23.24
Cash From Operations, 3 Yr. CAGR %	245.28	121.4	15.44	-39.58	-27.82
Capital Expenditures, 3 Yr. CAGR %	38.99	132.08	118.26	54.68	-21.7
Levered Free Cash Flow, 3 Yr. CAGR %	233.02	123.46	2.85	-30.74	-28.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	234.01	123.83	2.41	-30.88	-28.99
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	179.44	147.88	119.28	122.01	19.34
Gross Profit, 5 Yr. CAGR %	142.2	120.02	53.18	44.75	29.02
EBITDA, 5 Yr. CAGR %	130.34	108.35	56.26	48.79	31.32
EBITA, 5 Yr. CAGR %	126.35	103.58	59.3	48.52	32.14
EBIT, 5 Yr. CAGR %	126.35	103.58	59.3	48.52	32.14
Earnings From Cont. Operations, 5 Yr. CAGR %	124.03	100.84	65.06	47.27	30.45
Net Income, 5 Yr. CAGR %	124.03	100.84	65.06	47.27	30.45
Normalized Net Income, 5 Yr. CAGR %	128.6	106.6	58.2	47.13	30.01
Diluted EPS Before Extra, 5 Yr. CAGR %	49.47	36.9	20.02	42.98	29.91
Accounts Receivable, 5 Yr. CAGR %	197.94	152.79	134.48	131.63	-33.27
Inventory, 5 Yr. CAGR %	-	-	-	-	26.62
Net Property, Plant and Equip., 5 Yr. CAGR %	76.3	72.75	65.83	59.32	49.11
Total Assets, 5 Yr. CAGR %	77.07	88.57	56.51	54.83	10.95
Tangible Book Value, 5 Yr. CAGR %	111.43	103.25	55.15	55.87	27.27
Common Equity, 5 Yr. CAGR %	111.43	103.25	55.37	56.13	27.56
Cash From Operations, 5 Yr. CAGR %	189.71	71.94	56.62	45.61	-1.57
Capital Expenditures, 5 Yr. CAGR %	53.67	46.94	46.22	101.04	23.07
Levered Free Cash Flow, 5 Yr. CAGR %	-	93.35	56.78	56.51	-9.54
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	93.56	56.71	56.36	-9.68